Abstract:Despite the effectiveness of insulin injections in managing hyperglycemia in type 1 diabetes mellitus (T1DM), they fall short in addressing autoimmunity and regenerating damaged islets. This review aims to explore the potential and prospects of emerging treatment modalities for T1DM, including mesenchymal stem cells (MSCs), MSC-derived exosomes, gene therapy, islet allotransplantation, pancreatic islet cell transplantation, and teplizumab. We review emerging treatment modalities for T1DM, highlighting several promising strategies with varied mechanisms and outcomes. Mesenchymal stem cells demonstrate potential in modulating the immune response and preserving or restoring beta-cell function, although variability in sources and administration routes necessitates further standardization. Similarly, MSC-derived exosomes show promise in promoting beta-cell regeneration and immune regulation, supported by early-stage studies showing improved glucose homeostasis in animal models, albeit with limited clinical data. Gene therapy, utilizing techniques like CRISPR-Cas9, offers targeted correction of genetic defects and immune modulation; however, challenges in precise delivery and ensuring long-term safety persist. Islet allotransplantation and pancreatic islet cell transplantation have achieved some success in restoring insulin independence, yet challenges such as donor scarcity and immunosuppression-related complications remain significant. Teplizumab, an anti-CD3 monoclonal antibody, has demonstrated potential in delaying T1DM onset by modulating immune responses and preserving beta-cell function, with clinical trials indicating prolonged insulin production capability. Despite significant progress, standardization, long-term efficacy, and safety continue to pose challenges across these modalities. Conclusion: While these therapies demonstrate significant potential, challenges persist. Future research should prioritize optimizing these treatments and validating them through extensive clinical trials to enhance T1DM management and improve patient outcomes.

Advances and challenges of the cell-based therapies among diabetic patients

Cell‐based therapy for diabetic cardiovascular complications: Prospects and challenges

Cell Therapy in Diabetes: Current Progress and Future Prospects

Advancing diabetes management: Exploring pancreatic beta-cell restoration's potential and challenges

Current progress of human trials using stem cell therapy as a treatment for diabetes mellitus.

Stem cells therapy for diabetes: from past to future

Advanced therapy to cure diabetes: mission impossible is now possible?

Efficacy of Stem Cell Application in Diabetes Mellitus: Promising Future Therapy for Diabetes and Its Complications

Revolutionary Role of Stem Cell Therapy Coupled with Modern AI Based Technologies in Diabetes Management and Remission

Diabetes current and future translatable therapies

Harnessing cellular therapeutics for type 1 diabetes mellitus: progress, challenges, and the road ahead

Research and application of cell transplantation in the treatment of diabetes mellitus: a review]

Emerging therapeutic options in the management of diabetes: recent trends, challenges and future directions

The efficiency of stem cell differentiation into functional beta cells for treating insulin-requiring diabetes: Recent advances and current challenges

Advancing diabetes treatment: the role of mesenchymal stem cells in islet transplantation

Recent progress in modeling and treating diabetes using stem cell-derived islets

Current status of stem cell therapy for type 1 diabetes: a critique and a prospective consideration

Exploring Novel Treatment Modalities for Type 1 Diabetes Mellitus: Potential and Prospects

Urine-derived stem cell therapy for diabetes mellitus and its complications: progress and challenges

Cell Replacement Therapy of Type Ⅰ Riabetes Mellitus